01 1Viatris
01 1RISPERIDONE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-05-04
Pay. Date : 2015-04-06
DMF Number : 17520
Submission : 2004-07-13
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RISPERIDONE USP, with a corresponding US DMF Number 17520.
Remarkably, this DMF maintains an Active status since its submission on July 13, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 04, 2015, and payment made on April 06, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
